ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 158 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $793,000 | -51.6% | 23,056 | -59.4% | 0.02% | -45.0% |
| Q4 2016 | $1,639,000 | +173.2% | 56,829 | +201.1% | 0.04% | +185.7% |
| Q3 2016 | $600,000 | -41.5% | 18,872 | -40.2% | 0.01% | -33.3% |
| Q2 2016 | $1,025,000 | +105.4% | 31,576 | +125.6% | 0.02% | +162.5% |
| Q4 2015 | $499,000 | +89.7% | 13,995 | +75.9% | 0.01% | +100.0% |
| Q3 2015 | $263,000 | -57.2% | 7,956 | -45.7% | 0.00% | -63.6% |
| Q2 2015 | $614,000 | +137.1% | 14,659 | +79.6% | 0.01% | +175.0% |
| Q4 2014 | $259,000 | -77.0% | 8,160 | -82.1% | 0.00% | -81.8% |
| Q3 2014 | $1,127,000 | +145.0% | 45,537 | +123.5% | 0.02% | +214.3% |
| Q2 2014 | $460,000 | +46.5% | 20,379 | +61.9% | 0.01% | +133.3% |
| Q4 2013 | $314,000 | +2.6% | 12,589 | +12.8% | 0.00% | -25.0% |
| Q3 2013 | $306,000 | – | 11,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |